FDA Adverse Event Malfunction Summary report: N

CLEARLINK DUO-VENT CONTINU-FLO SOLUTION SET

MDR report key: 14488608 · Received May 24, 2022

Report

Report Number
1416980-2022-02610
Event Type
Malfunction
Date Received
May 24, 2022
Date of Event
April 28, 2022
Report Date
June 27, 2022
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
FPA
PMA / PMN Number
K203609
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INITIAL REPORTER PHONE NO. (B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

B5: THE AFFECTED PRODUCT IS "CLEARLINK SYSTEM CONTINU-FLO SOLUTION SET"; PREVIOUSLY SUBMITTED AS "UNSPECIFIED PRIMARY IV (INTRAVENOUS) TUBING SET". D1: THE UPDATE TO BRAND NAME IS "CLEARLINK DUO-VENT CONTINU-FLO SOLUTION SET"; PREVIOUSLY SUBMITTED AS NI D4: THE UPDATE TO PRODUCT CODE IS "2C8541"; PREVIOUSLY SUBMITTED AS ASKU G1: THE UPDATED MANUFACTURING FACILITY IS BAXTER HEALTHCARE - CARTAGO 600 MTS. OESTE DE ENTRADA, PRINCIPAL AVE. LAS AMERICAS, PARQUE INDUSTRIAL CARTAGO COSTA RICA 30106 G4: THE 510K # IS "K203609"; PREVIOUSLY SUBMITTED AS "NA" H10: THE DEVICE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE CONNECTOR OF AN UNSPECIFIED PRIMARY IV (INTRAVENOUS) TUBING SET WAS FOUND TO BE COMPLETELY SMASHED. THIS WAS OBSERVED AFTER PRIMING THE SET WITH MEDICATION WHEN THE NURSE REMOVED THE CAP. THERE WAS NO REPORT OF PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1473965 CLEARLINK DUO-VENT CONTINU-FLO SOLUTION SET SET, ADMINISTRATION, INTRAVASCULAR FPA BAXTER HEALTHCARE CORPORATION NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 Unknown